These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 32038630)
1. Novel Immunomodulatory Proteins Generated via Directed Evolution of Variant IgSF Domains. Levin SD; Evans LS; Bort S; Rickel E; Lewis KE; Wu RP; Hoover J; MacNeil S; La D; Wolfson MF; Rixon MW; Dillon SR; Kornacker MG; Swanson R; Peng SL Front Immunol; 2019; 10():3086. PubMed ID: 32038630 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses. Watanabe M; Takagi Y; Kotani M; Hara Y; Inamine A; Hayashi K; Ogawa S; Takeda K; Tanabe K; Abe R J Immunol; 2008 Apr; 180(8):5222-34. PubMed ID: 18390703 [TBL] [Abstract][Full Text] [Related]
3. Structural basis of inducible costimulator ligand costimulatory function: determination of the cell surface oligomeric state and functional mapping of the receptor binding site of the protein. Chattopadhyay K; Bhatia S; Fiser A; Almo SC; Nathenson SG J Immunol; 2006 Sep; 177(6):3920-9. PubMed ID: 16951355 [TBL] [Abstract][Full Text] [Related]
4. Discovery of receptor-ligand interfaces in the immunoglobulin superfamily. Gil N; Fajardo EJ; Fiser A Proteins; 2020 Jan; 88(1):135-142. PubMed ID: 31298437 [TBL] [Abstract][Full Text] [Related]
5. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. McAdam AJ; Chang TT; Lumelsky AE; Greenfield EA; Boussiotis VA; Duke-Cohan JS; Chernova T; Malenkovich N; Jabs C; Kuchroo VK; Ling V; Collins M; Sharpe AH; Freeman GJ J Immunol; 2000 Nov; 165(9):5035-40. PubMed ID: 11046032 [TBL] [Abstract][Full Text] [Related]
7. Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis. O'Dwyer R; Kovaleva M; Zhang J; Steven J; Cummins E; Luxenberg D; Darmanin-Sheehan A; Carvalho MF; Whitters M; Saunders K; Barelle CJ J Immunol Res; 2018; 2018():4089459. PubMed ID: 30417018 [TBL] [Abstract][Full Text] [Related]
8. Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation. Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK J Immunol; 2002 Nov; 169(10):5780-6. PubMed ID: 12421958 [TBL] [Abstract][Full Text] [Related]
9. Functional clustering of immunoglobulin superfamily proteins with protein-protein interaction information calibrated hidden Markov model sequence profiles. Yap EH; Rosche T; Almo S; Fiser A J Mol Biol; 2014 Feb; 426(4):945-61. PubMed ID: 24246499 [TBL] [Abstract][Full Text] [Related]
10. Abrogation of ICOS/ICOS ligand costimulation in NOD mice results in autoimmune deviation toward the neuromuscular system. Prevot N; Briet C; Lassmann H; Tardivel I; Roy E; Morin J; Mak TW; Tafuri A; Boitard C Eur J Immunol; 2010 Aug; 40(8):2267-76. PubMed ID: 20544729 [TBL] [Abstract][Full Text] [Related]
11. Estimating the accuracy of pharmacophore-based detection of cognate receptor-ligand pairs in the immunoglobulin superfamily. Gil N; Shrestha R; Fiser A Proteins; 2021 Jun; 89(6):632-638. PubMed ID: 33483991 [TBL] [Abstract][Full Text] [Related]
12. The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis. Wiendl H; Neuhaus O; Mehling M; Wintterle S; Schreiner B; Mitsdoerffer M; Wienhold W; Weissert R; Wessels J; Hartung HP; Weller M; Tolosa E; Melms A J Neuroimmunol; 2003 Jul; 140(1-2):177-87. PubMed ID: 12864987 [TBL] [Abstract][Full Text] [Related]
13. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes. Parry RV; Rumbley CA; Vandenberghe LH; June CH; Riley JL J Immunol; 2003 Jul; 171(1):166-74. PubMed ID: 12816995 [TBL] [Abstract][Full Text] [Related]
14. Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigen. Hayden MS; Grosmaire LS; Norris NA; Gilliland LK; Winberg G; Tritschler D; Tsu TT; Linsley PS; Mittler RS; Senter PD; Fell HP; Ledbetter JA Tissue Antigens; 1996 Oct; 48(4 Pt 1):242-54. PubMed ID: 8946677 [TBL] [Abstract][Full Text] [Related]
15. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. Girvin AM; Dal Canto MC; Rhee L; Salomon B; Sharpe A; Bluestone JA; Miller SD J Immunol; 2000 Jan; 164(1):136-43. PubMed ID: 10605004 [TBL] [Abstract][Full Text] [Related]
16. Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains. Alabanza L; Pegues M; Geldres C; Shi V; Wiltzius JJW; Sievers SA; Yang S; Kochenderfer JN Mol Ther; 2017 Nov; 25(11):2452-2465. PubMed ID: 28807568 [TBL] [Abstract][Full Text] [Related]
18. Characterization of human inducible costimulator ligand expression and function. Aicher A; Hayden-Ledbetter M; Brady WA; Pezzutto A; Richter G; Magaletti D; Buckwalter S; Ledbetter JA; Clark EA J Immunol; 2000 May; 164(9):4689-96. PubMed ID: 10779774 [TBL] [Abstract][Full Text] [Related]
19. Comparable in vivo efficacy of CD28/B7, ICOS/GL50, and ICOS/GL50B costimulatory pathways in murine tumor models: IFNgamma-dependent enhancement of CTL priming, effector functions, and tumor specific memory CTL. Zuberek K; Ling V; Wu P; Ma HL; Leonard JP; Collins M; Dunussi-Joannopoulos K Cell Immunol; 2003 Sep; 225(1):53-63. PubMed ID: 14643304 [TBL] [Abstract][Full Text] [Related]